The current study investigates whether the ASPI-score is sensitive to context in which the ASPI is administered. Because the ASPI was designed to measure the capacity to experience sexual pleasure, it is expected that the ASPI score will not vary…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
geen aandoeningen/ (aandoeningen in de seksuele beleving)
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
- ASPI score: sexual pleasure
Secondary outcome
1.
- FSFI: sexual functioning
- FSDS-R: sexual distress
- SOS: sexual attitudes
- SAQ: positive/negative affect towards sexual stimuli
- ECR-R: attachment-anxiety
- Orgasm consistency
2. Genital response measured as Vaginal Pulse Amplitude (VPA) during:
- high and low female-friendly erotic film-fragments (explicit sexual film
fragments, depicting fellatio, cunnilungus en penetration + clitoral vibration
during the high erotic film-fragment)
3. Subjective arousal, measured by questions about
- overall feeling of sexual arousal
- stongest feeling of sexual arousal
- strongest genital sensation
- subjectively estimated amount of vaginal lubrication
Background summary
A recent study (not yet published) found a clear factor structure for the ASPI
and satisfactory to good psychometric properties. The ASPI was found to be able
to discriminate between people with and without sexual dysfunctions. This study
gave insight into the correlates and determinants of sexual pleasure (as
measured by the ASPI). However, more research is needed to determine if this
questionnaire measures a trait or a state. A trait is stable over time and
context. A state varies per situation. IN the current study the ASPI is
administered in two different contexts (erotic and neutral).
Study objective
The current study investigates whether the ASPI-score is sensitive to context
in which the ASPI is administered. Because the ASPI was designed to measure the
capacity to experience sexual pleasure, it is expected that the ASPI score will
not vary with contexts. It is also investigated to what extent the ASPI is
related to orgasm consistency (the ease with which individuals have an orgasm
in sexual situations). Also, convergent validity will be investigated using
other validated questionnaires (sexual function questionnaires and emotional
attachment). Exploratory, it will be investigated to what extent the
interaction between genital and self-reported subjective sexual arousal is
related to the ASPI-score.
Study design
Two (context) x two (context-order) design with context as within-subjects
factor, context-order as between-subjects factor and the ASPI score as
dependent variabele will be tested wit Bayesian statistics, and a correlational
study investigating the relationship between the ASPI and other variables.
Study burden and risks
We do not expect any risks. The burden consists of filling in questionnaires
(that contain intimate questions) and a psychophysiological experiment
involving measurement of vaginal vasocongestion.
If the questionnaires and/or the psychophysiological test are mentally taxing
for the participant, help will be offered.
Meibergdreef 9 Meibergdreef 9
Amsterdam 1105 AZ
NL
Meibergdreef 9 Meibergdreef 9
Amsterdam 1105 AZ
NL
Listed location countries
Age
Inclusion criteria
-Female
-Aged 18+
-Willing to look at erotic, heterosexual only, film-fragments
-Sexual experience with another person (including stimulation of genitalia)
-Understanding of Dutch language
-Able and willing to provide informed consent
Exclusion criteria
-Vaginal infection(s)
-Chronic disease
-Vaginal surgery
-Mental illness (diagnosis by psychiatrist or psychologist)
-Oophorectomy or radiation of the ovaries
-Lactation or pregnancy six months prior to study start
-Not willing to look at erotic, heterosexual only, film-fragments
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL54189.018.15 |